| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS30075857 | HIV | ENSG00000165194.15 | protein_coding | PCDH19 | No | No | 57526 | B3KU71 Q8TAB3 |
| TVIS20001998 | HPV | ENSG00000165194.15 | protein_coding | PCDH19 | No | No | 57526 | B3KU71 Q8TAB3 |
| TVIS20005972 | HPV | ENSG00000165194.15 | protein_coding | PCDH19 | No | No | 57526 | B3KU71 Q8TAB3 |
| TVIS20016917 | HPV | ENSG00000165194.15 | protein_coding | PCDH19 | No | No | 57526 | B3KU71 Q8TAB3 |
| TVIS44011605 | HTLV-1 | ENSG00000165194.15 | protein_coding | PCDH19 | No | No | 57526 | B3KU71 Q8TAB3 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | PCDH19 |
|---|---|
| DrugBank ID | DB01373 |
| Drug Name | Calcium |
| Target ID | BE0005814 |
| UniProt ID | Q8TAB3 |
| Regulation Type | |
| PubMed IDs | 18469813 |
| Citations | Dibbens LM, Tarpey PS, Hynes K, Bayly MA, Scheffer IE, Smith R, Bomar J, Sutton E, Vandeleur L, Shoubridge C, Edkins S, Turner SJ, Stevens C, O'Meara S, Tofts C, Barthorpe S, Buck G, Cole J, Halliday K, Jones D, Lee R, Madison M, Mironenko T, Varian J, West S, Widaa S, Wray P, Teague J, Dicks E, Butler A, Menzies A, Jenkinson A, Shepherd R, Gusella JF, Afawi Z, Mazarib A, Neufeld MY, Kivity S, Lev D, Lerman-Sagie T, Korczyn AD, Derry CP, Sutherland GR, Friend K, Shaw M, Corbett M, Kim HG, Geschwind DH, Thomas P, Haan E, Ryan S, McKee S, Berkovic SF, Futreal PA, Stratton MR, Mulley JC, Gecz J: X-linked protocadherin 19 mutations cause female-limited epilepsy and cognitive impairment. Nat Genet. 2008 Jun;40(6):776-81. doi: 10.1038/ng.149. Epub 2008 May 11. |
| Groups | Nutraceutical |
| Direct Classification | |
| SMILES | [Ca] |
| Pathways | Lidocaine (Antiarrhythmic) Action Pathway; Reteplase Action Pathway; Arachidonic Acid Metabolism; Oxaprozin Action Pathway; Ardeparin Action Pathway; Heparin Action Pathway; Mefenamic Acid Action Pathway; Bromfenac Action Pathway; Riboflavin Metabolism; Alprenolol Action Pathway; Naproxen Action Pathway; Procainamide (Antiarrhythmic) Action Pathway; Sphingolipid Metabolism; Tranexamic Acid Action Pathway; Xanthine Dehydrogenase Deficiency (Xanthinuria); Meloxicam Action Pathway; Phenprocoumon Action Pathway; Streptokinase Action Pathway; Phenylketonuria; Gaucher Disease; Fc Epsilon Receptor I Signaling in Mast Cells; Ketorolac Action Pathway; Androgen and Estrogen Metabolism; Acetylsalicylic Acid Action Pathway; Bivalirudin Action Pathway; Aprotinin Action Pathway; Alpha Linolenic Acid and Linoleic Acid Metabolism; Malate-Aspartate Shuttle; Folate Metabolism; Adenylosuccinate Lyase Deficiency |
| PharmGKB | PA164712582 |
| ChEMBL |
